Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BKNG | BOOKING HOLDINGS INC | $128.58B | $165.93 | $48.90k | 29,373.09% | Strong Buy | 26 | 8.67% | 23.95% | -151.02% | 47.53% | |||
| FBLG | FIBROBIOLOGICS INC | $6.04M | $1.16 | $74.00 | 6,279.31% | Strong Buy | 2 | N/A | N/A | -1,077.94% | -471.99% | |||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $11.02M | $0.86 | $38.20 | 4,341.86% | Strong Buy | 5 | N/A | N/A | -63.46% | -34.47% | |||
| SNYR | SYNERGY CHC CORP | $4.42M | $0.39 | $6.25 | 1,498.47% | Strong Buy | 2 | 47.58% | N/A | -25.18% | 57.28% | |||
| VNRX | VOLITIONRX LTD | $17.83M | $2.25 | $33.33 | 1,381.47% | Strong Buy | 3 | 254.03% | N/A | -14.16% | 70.27% | |||
| AIRE | REALPHA TECH CORP | $11.91M | $2.22 | $32.50 | 1,363.96% | Buy | 2 | 133.43% | N/A | -116.18% | -54.30% | |||
| NRXP | NRX PHARMACEUTICALS INC | $101.85M | $3.08 | $38.25 | 1,141.88% | Strong Buy | 4 | 843.02% | N/A | -1,161.90% | 1,429.24% | |||
| IMMP | IMMUTEP LTD | $65.73M | $0.45 | $5.50 | 1,133.18% | Buy | 2 | N/A | N/A | N/A | N/A | |||
| OSTX | OS THERAPIES INC | $65.63M | $1.66 | $18.50 | 1,014.46% | Strong Buy | 2 | N/A | N/A | N/A | -51.10% | |||
| NRSN | NEUROSENSE THERAPEUTICS LTD | $28.65M | $0.88 | $8.50 | 865.91% | Strong Buy | 2 | N/A | N/A | -6,492.65% | 9,852.66% | |||
| RNXT | RENOVORX INC | $38.95M | $0.86 | $8.25 | 854.86% | Buy | 2 | 216.82% | N/A | 737.74% | 494.14% | |||
| ENGN | ENGENE THERAPEUTICS INC | $100.48M | $1.50 | $14.19 | 845.87% | Buy | 8 | N/A | N/A | -4.47% | -3.73% | |||
| FEMY | FEMASYS INC | $25.97M | $0.43 | $4.00 | 830.23% | Strong Buy | 2 | 136.75% | N/A | -25.35% | -11.20% | |||
| HELP | CYBIN INC | $264.94M | $5.31 | $49.00 | 822.79% | Strong Buy | 4 | N/A | N/A | N/A | N/A | |||
| SXTP | 60 DEGREES PHARMACEUTICALS INC | $4.06M | $1.54 | $14.10 | 815.58% | Buy | 2 | 115.99% | N/A | -34.17% | -22.05% | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $33.03M | $1.22 | $11.00 | 801.64% | Strong Buy | 2 | 318.23% | N/A | N/A | -38.73% | |||
| PSTV | PLUS THERAPEUTICS INC | $42.00M | $6.12 | $55.00 | 798.69% | Strong Buy | 3 | 107.29% | N/A | 408.12% | 99.90% | |||
| CTSO | CYTOSORBENTS CORP | $38.18M | $0.61 | $5.38 | 782.59% | Buy | 2 | 16.28% | N/A | N/A | N/A | |||
| SNTI | SENTI BIOSCIENCES INC | $30.71M | $0.99 | $8.50 | 762.07% | Strong Buy | 2 | 631.46% | N/A | -571.23% | -62.33% | |||
| CMPX | COMPASS THERAPEUTICS INC | $329.56M | $1.83 | $15.50 | 746.99% | Strong Buy | 6 | N/A | N/A | 46.79% | 42.53% | |||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $119.49M | $0.97 | $8.00 | 728.16% | Strong Buy | 2 | 114.76% | N/A | -110.84% | -62.41% | |||
| HOWL | WEREWOLF THERAPEUTICS INC | $33.05M | $0.68 | $5.50 | 708.82% | Strong Buy | 2 | N/A | N/A | -406.23% | -85.43% | |||
| GUTS | FRACTYL HEALTH INC | $119.78M | $0.76 | $6.00 | 694.70% | Buy | 3 | N/A | N/A | 114.06% | 8.89% | |||
| RCT | REDCLOUD HOLDINGS PLC | $29.45M | $0.67 | $5.25 | 688.29% | Strong Buy | 2 | N/A | N/A | N/A | -1.68% | |||
| LUNG | PULMONX CORP | $53.22M | $1.26 | $9.50 | 653.97% | Strong Buy | 2 | 14.62% | N/A | 144.51% | 55.12% | |||
| INTZ | INTRUSION INC | $15.68M | $0.77 | $5.75 | 646.75% | Buy | 2 | 25.34% | N/A | -85.65% | -60.01% | |||
| PDSB | PDS BIOTECHNOLOGY CORP | $69.77M | $1.25 | $9.00 | 620.00% | Strong Buy | 2 | N/A | N/A | 276.91% | 84.01% | |||
| AVXL | ANAVEX LIFE SCIENCES CORP | $298.40M | $3.22 | $22.00 | 583.23% | Strong Buy | 2 | N/A | N/A | 347.89% | 331.22% | |||
| ACRV | ACRIVON THERAPEUTICS INC | $76.71M | $1.98 | $13.50 | 581.82% | Strong Buy | 2 | N/A | N/A | -57.52% | -49.89% | |||
| PEPG | PEPGEN INC | $121.64M | $1.76 | $11.75 | 567.61% | Strong Buy | 4 | N/A | N/A | -39.37% | -33.38% | |||
| CING | CINGULATE INC | $61.28M | $5.27 | $34.50 | 554.65% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| OCGN | OCUGEN INC | $511.17M | $1.51 | $9.75 | 545.70% | Strong Buy | 4 | 242.84% | N/A | 2,478.41% | 252.83% | |||
| CRDL | CARDIOL THERAPEUTICS INC | $132.34M | $1.32 | $8.50 | 543.94% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| KSCP | KNIGHTSCOPE INC | $48.69M | $2.99 | $19.00 | 535.45% | Buy | 2 | 172.43% | N/A | -162.10% | -109.09% | |||
| BEAT | HEARTBEAM INC | $36.57M | $0.89 | $5.63 | 532.02% | Strong Buy | 4 | N/A | N/A | -298.33% | -132.90% | |||
| CCCC | C4 THERAPEUTICS INC | $287.86M | $2.95 | $18.50 | 527.12% | Strong Buy | 2 | -20.49% | N/A | -49.07% | -35.06% | |||
| CBUS | CIBUS INC | $99.64M | $1.44 | $9.00 | 525.00% | Buy | 2 | 118.18% | N/A | 562.60% | 40.26% | |||
| AUTL | AUTOLUS THERAPEUTICS PLC | $417.84M | $1.57 | $9.67 | 515.73% | Buy | 3 | 59.73% | N/A | -6.84% | -2.07% | |||
| ALT | ALTIMMUNE INC | $401.92M | $3.09 | $19.00 | 514.89% | Strong Buy | 2 | 1,087.56% | N/A | 40.70% | 32.70% | |||
| ALGS | ALIGOS THERAPEUTICS INC | $39.85M | $6.44 | $39.33 | 510.76% | Strong Buy | 3 | 75.95% | N/A | 105.43% | 51.92% | |||
| HOVR | NEW HORIZON AIRCRAFT LTD | $108.18M | $2.39 | $14.50 | 506.69% | Strong Buy | 2 | N/A | N/A | -349.78% | -225.58% | |||
| BMEA | BIOMEA FUSION INC | $111.34M | $1.54 | $9.33 | 506.04% | Strong Buy | 3 | N/A | N/A | -254.54% | -128.42% | |||
| CRBU | CARIBOU BIOSCIENCES INC | $192.41M | $1.94 | $11.67 | 501.39% | Strong Buy | 3 | 42.16% | N/A | -137.84% | -94.38% | |||
| MREO | MEREO BIOPHARMA GROUP PLC | $39.90M | $0.25 | $1.50 | 500.00% | Buy | 3 | 340.35% | N/A | -100.26% | -89.34% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.